IHA Hematology Oncology Consultants-Chelsea — Chelsea, Michigan

IHA Hematology Oncology Consultants-Chelsea is a clinical research site located in Chelsea, Michigan, United States 48118.

Crixeo Clinical Trials Trust Score: 26/100 (FAILING). This profile has not yet been claimed by the site owner.

IHA Hematology Oncology Consultants-Chelsea has participated in 47 clinical trials with 14 currently active.

Therapeutic areas: Myelodysplastic Syndromes (MDS), Endometrial Endometrioid Adenocarcinoma, Variant With Squamous Differentiation, Endometrial Mucinous Adenocarcinoma.

Sponsors: National Heart, Lung, and Blood Institute (NHLBI), GOG Foundation, ECOG-ACRIN Cancer Research Group.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Chelsea

Browse all research sites in Michigan · View every site in Chelsea

• Trinity Health IHA Hematology Oncology Consultants-Chelsea Hospital
• Chelsea Hospital
• Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital
• Saint Joseph Mercy Hospital - Chelsea
• University of Michigan / Chelsea Health Center
• Chelsea Community Hospital
• St. Joseph Health System Chelsea Hospital
• Saint Joseph Mercy Chelsea
• Research Site
• IHA Chelsea Family & Internal Medicine
• St Joseph Mercy-Chelsea

Sponsor Feasibility Report

Trust Score: 26/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for IHA Hematology Oncology Consultants-Chelsea?

IHA Hematology Oncology Consultants-Chelsea has a Crixeo Trust Score of 26/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has IHA Hematology Oncology Consultants-Chelsea conducted?

IHA Hematology Oncology Consultants-Chelsea has 47 clinical trials on record, with 14 currently active. Their work covers Myelodysplastic Syndromes (MDS), Endometrial Endometrioid Adenocarcinoma, Variant With Squamous Differentiation, Endometrial Mucinous Adenocarcinoma.

Is IHA Hematology Oncology Consultants-Chelsea accredited by Crixeo Clinical Trials?

IHA Hematology Oncology Consultants-Chelsea has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about IHA Hematology Oncology Consultants-Chelsea?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.